Somerset Medical Center Delays Reporting Suspected Poisonings

Somerset Medical Center Delays Reporting Suspected Poisonings describes the dispute over who should act—and how quickly—after a group of patients experienced unexplained, potentially criminal drug exposures. The hospital wanted more information before making a formal report; New Jersey Poison Control Center director Steven Marcus regarded the emerging pattern as an urgent patient-safety matter that belonged with state officials and police. The delay exposed a conflict between internal investigation and the duty to report, while leaving the possibility of further harm unresolved.

The warning and the hospital’s hesitation

The exchange began after Bruce Ruck, a pharmacist at the New Jersey Poison Control Center, had contacted Somerset Medical Center about the suspected incidents. The center’s director, Steven Marcus, heard Ruck’s account and quickly concluded that the data were not ambiguous: he believed someone at the hospital might be deliberately killing patients. His concern was not only what had already happened, but what could happen while the hospital waited to acknowledge the pattern.

A day later, the center was still waiting for a response. Ruck called the hospital pharmacy again and reached Stuart Vigdor, the head of pharmacy and Nancy Doherty’s supervisor. He adopted a friendly, informal tone and asked what the hospital had decided. In a later conference call, Ruck asked whether two other patients had also experienced unusual glucose readings. Mary Lund confirmed that they had. Ruck protected Doherty as his source, directing the conversation toward whether the hospital had tested insulin and C-peptide levels rather than identifying who had raised the concern.

Somerset’s administrators described themselves as uncertain and still investigating. They were weighing the danger of disrupting the institution against their responsibility to prevent further harm, and wanted expert opinion before reaching a judgment. When Marcus asked whether he should come in to examine the records, the hospital’s representative, Cors, suggested ending the call so the administration could consult its lawyers and decide what to do. Marcus agreed that legal counsel should be involved, but urged them not to waste time. He had seen investigations falter when hospitals treated clusters of crashing patients as clinical puzzles and administrators treated them chiefly as potential lawsuits. In those earlier cases, delay before calling police had allowed people to die.

A reporting deadline—and an escalation

In another conference call, Marcus stated that Somerset was obligated to report the incidents to the state within twenty-four hours and was already failing to meet that obligation. The hospital maintained that it would not report to the New Jersey Department of Health and Senior Services or the police until it had completed a thorough investigation. Marcus’s response grew increasingly forceful: he insisted that the matter concerned patient safety and the police, gave the hospital twenty-four hours to act, and warned that it would look worse if he had to report the problem himself.

That warning was not an empty threat. Earlier that afternoon, Marcus had already called Eddy Bresnitz, the state epidemiologist and assistant commissioner of health, to describe a cluster of hospital illnesses that might result from criminal acts. He also emailed Amie Thornton, an assistant commissioner, summarizing four troubling clinical events and Somerset’s unwillingness to report them before completing its own investigation. The sequence matters: Marcus disclosed his intervention to the hospital during the call, but state officials had already been alerted independently.

About twenty minutes into the conversation, Marcus also told the Somerset administrators that all their conversations had been recorded. The disclosure made the disagreement harder to treat as an informal consultation: both the hospital’s reluctance and the poison-control director’s warnings had become part of a preserved record. A few hours later, Mary Lund reported the four incidents to the state. The cases included Reverend Florian Gall and Jin Kyung Han, whose incidents involved digoxin, and two other patients whose incidents involved insulin.

The internal inquiry and its limits

Lund’s report described steps Somerset had taken to test less alarming explanations. The hospital had checked for manufacturer recalls and adverse drug interactions, confirmed that intravenous equipment and bedside monitors were functioning accurately, and repeated laboratory tests to rule out lab error. As a precaution, it tightened pharmacy controls on digoxin, following similar controls on insulin. Nurses would be held more accountable for these commonly used drugs, making them harder to obtain if someone was using them to harm patients.

The administration still considered human error the likeliest explanation. Medication mistakes were possible, and the hospital told the state that it was reviewing its documentation systems for evidence of an innocent error. Somerset used the Pyxis MedStation medication-dispensing system for drugs and the Cerner electronic medical-record system for patient charts; its review had not yet uncovered an innocent mistake. The absence of such a paper trail did not establish who had caused the incidents, but it weakened the most straightforward account of an accidental medication error.

The hospital’s own correspondence also acknowledged a darker possibility. A July 10 letter from Lund said that human-resource factors were being evaluated and that independent investigators were interviewing staff involved. On July 14, attorney Raymond J. Fleming came to Somerset Medical Center, received a briefing from Lund, and arranged to meet Charles Cullen. That interview shows the investigation moving toward scrutiny of an individual nurse, but it does not erase the earlier dispute over whether the incidents should have been reported sooner.

Consequences and significance

The hospital’s eventual report brought four incidents and Somerset’s preliminary investigative steps to the state’s attention, while the added controls on insulin and digoxin sought to restrict access to drugs that might be used to injure patients. Yet the response remained divided among distinct functions: the hospital investigated its records and staff, Poison Control pressed for urgent action, and state officials received information through Marcus before Somerset submitted its own account. The narrative does not present those steps as interchangeable. Internal inquiry might identify what happened, but it could not substitute for a timely external report when the suspected cause was criminal harm.

The delay is therefore consequential less as a single refusal than as a contest over the threshold for action. Somerset sought more certainty before involving outside authorities; Marcus argued that uncertainty was precisely why prompt reporting and forensic investigation mattered. His insistence that the records be examined, his deadline, his prior contact with state officials, and his disclosure that the calls were recorded each narrowed the room for indefinite deferral. The episode frames reporting not as paperwork after an investigation, but as part of the safeguard meant to prevent an unresolved pattern from continuing.